Soligenix $SNGX receives European patent to treat inflammatory GI diseases with topically active steroids, http://bit.ly/dhuo6o

Soligenix $SNGX completes patient enrollment in Phase 2 Acute GVHD Prevention clinical trial http://www.soligenix.com/news.aspx?titleId=347

Soligenix $SNGX Reports First Quarter 2010 Financial Results and Reviews Accomplishments http://www.soligenix.com/news.aspx?titleId=348

Soligenix $SNGX Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral BDP http://bit.ly/dc341U

Soligenix $SNGX Announces Grant of European Patent for the Treatment of GVHD and Leukemia with Oral BDP http://bit.ly/9uxbk9

Soligenix $SNGX Announces Financing of $5.16 Million with its Partner Sigma-Tau and other Institutional Investors http://bit.ly/czkUQ8

Soligenix $SNGX Publishes Positive Data on Protection from Ricin Intoxication by Intradermal RiVax™ Administration http://bit.ly/9f5n5O

Soligenix ($SNGX) to Present at the OneMedForum Conference in New York City on Wednesday, June 30th at 2PM EDT

Soligenix ($SNGX) to Present at the OneMedForum Conference on Wednesday, June 30th at 2PM EDT http://bit.ly/aZzvw0

Soligenix ($SGNX) Reports Second Quarter 2010 Financial Results and Reviews Accomplishments http://www.soligenix.com/news.aspx?titleId=354

Soligenix ($SGNX) Announces Award of $1.2 Million FDA Orphan Products Development Grant http://www.soligenix.com/news.aspx?titleId=355

Soligenix ($SNGX) Publication Identifying Domains Within the Ricin Toxin A Subunit as Targets of Protective Antibodies http://bit.ly/ag1XkU

Soligenix ($SNGX) Provides Corporate Update - Announces Election of Tamar D. Howson and Virgil D. Thompson to Board http://bit.ly/cbUubb

Soligenix $SNGX initiates Phase 1/2 clinical trial for prevention of acute radiation enteritis http://soligenix.com/news.aspx?titleId=340

Soligenix, $SNGX, publishes positive results with RiVax, its vaccine against ricin toxin, http://soligenix.com/news.aspx?titleId=341

Soligenix, $SNGX, notes positive long-term stability results with RiVax, its vaccine against ricin toxin, http://tiny.cc/rivaxvacc

Soligenix, $SNGX, will present at BIO CEO & Investor Conference, http://soligenix.com/news.aspx?titleId=343

Soligenix, $SNGX, receives Hong Kong patent for its Lipid Polymer Micelle technology for improved oral drug delivery, http://tiny.cc/LPM

Soligenix, $SNGX, ricin toxin vaccine, biodefense work noted in Gene Marcial's Inside Wall Street, http://tinyurl.com/insidewallst

Soligenix $SNGX confirmatory Phase 3 trial of orBec® for GVHD noted in Seeking Alpha, http://tiny.cc/gvhdreview